Red Cell Alloimmunisation Among Sickle Cell Disease and Thalassemia Patients Following Rh- and K-Matched Red Cell Transfusion in Southwestern Saudi Arabia: A Multicenter Study

• Published in: International journal of general medicine Vol. 17; pp. 2855 - 2864
• Main Authors: Meshi, Abdullah Ahmed, Abu-Tawil, Hisham, Hamzi, Abdulrahman Ahmed, Madkhali, Basem Ali, Maghfori, Ali Bohais, Alnami, Ismail Ibrahim, Hamali, Hassan A, Madkhali, Maymoon Mohammed
• Format: Journal Article
• Language: English
• Published: Dove Medical Press Limited 30.06.2024; Dove Medical Press
• Subjects: alloantibodies; alloimmunisation; Antibodies; Antigen-antibody reactions; Antigens; Blood transfusion; Complications and side effects; Medical records; Medical research; Medicine, Experimental; red cell transfusion; Sickle cell anemia; sickle cell disease; Thalassemia; Viral antibodies; Saudi Arabia
• ISSN: 1178-7074; 1178-7074
• DOI: 10.2147/IJGM.S444949

Background: Alloimmunisation remains a major consequence of blood transfusion among sickle cell disease (SCD) and thalassemia patients due to the exposure to non-self-red blood cell (RBC) antigen. The complication is associated with transfusion reactions and delayed transfusion procedure because of the difficulty of finding compatible blood. This study aims to determine the prevalence of alloimmunisation to RBC and alloantibody specificities among SCD and thalassemia patients in, an endemic area of SCD and thalassemia, Jazan province of Saudi Arabia, from three major hospitals. Methods: This is a retrospective, multicenter cross-sectional study conducted on 1027 patients with SCD and thalassemia, which received Rh/K matched transfusions in 2019 in the three centers. Demographic data and medical records of participants from three transfusion institutions were collected and analysed. Results: A total of 1027 were enrolled in the cohort; 906 (88.2%) and 121 (11.8%) patients with SCD and thalassemia, respectively. There were 483 (47%) males and 544 (53%) females with median age of 15 (range 1-48). Among the studied population, 78 were alloimmunised with an overall alloimmunisation rate of 7.6%. These patients developed a total of 108 alloantibodies, and anti-E was the most detected antibody (25.9%) followed by anti-K (24.1%). Conclusion: The overall rate of alloimmunisation to RBC antigen among the studied population in Jazan was low compared to other areas in the country. Most alloantibodies detected were against E and K antigens. The knowledge of most encountered alloantibodies in our population will aid in selecting the most appropriate antigen-negative red cells. Further research, however, is needed to explore factors associated with residual risk of alloimmunisation in these patients. Keywords: sickle cell disease, thalassemia, red cell transfusion, alloimmunisation, alloantibodies